相关实验视频
Updated: Jun 16, 2025

09:16
Orthotopic Small Bowel Transplantation in Rats
Published on: November 6, 2012
14.2K
在短肠综合征和肠道衰竭的成年人中的泰杜格卢:描述性队列研究
Elizabeth S L Low1,2, Kathryn Burrell1, Katrina Tan1,2
1Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia.
JPEN. Journal of parenteral and enteral nutrition
|June 14, 2025
概括
泰杜格卢提德有效地减少了澳大利亚短肠综合征-肠衰竭患者的腹腔支需求. 虽然一些患者获得了肠道自主性,但治疗治疗.
科学领域:
- 胃肠病学和肝病学
- 临床治疗学 临床治疗学
- 父母肠道营养是一种营养.
背景情况:
- 短肠综合征-肠衰竭 (SBS-IF) 需要显著的肠外支持.
- 泰杜格卢提德是减少SBS-IF中关节支的既定疗法.
- 澳大利亚对泰杜格胺使用的真实数据有限.
研究的目的:
- 在澳大利亚SBS-IF队列中评估泰杜格卢的现实有效性.
- 评估降低亲肠道支需求和实现肠道自主性的减少.
- 为了确定患者的特征和与泰杜格胺治疗相关的结果.
主要方法:
- 多中心观察性研究涉及澳大利亚的19名成人SBS-IF患者.
- 数据收集在Teduglutide开始后的12个月内每3个月间隔收集的数据.
- 对亲肠支体积,肠内自主性和临床特征的分析.
主要成果:
- 37%的患者实现了肠道自主性,79%的患者经历了 ≥20%的肠道支减少.
- 经过12个月,中位数的亲肠道支体积减少为28%.
- 疾病负担严重影响性功能,旅行和睡眠,对生活质量产生了重大影响.
结论:
- 泰杜格卢提德在减少澳大利亚SBS-IF患者的肠道支需求方面表现出有效性.
- 治疗效应的开始和程度在个体之间是可变的.
- 进一步的研究可以优化Teduglutide治疗SBS-IF管理.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
329
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
92
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
92

